Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering aldosterone deficiency and pseudodeficiency in infancy by targeted GC-MS urinary steroid metabotyping. | J Steroid Biochem Mol Biol | 2027 | 42603653 | PubTator, text mining | PubMed |
| Emerging therapeutics in hypertension: Evidence, clinical readiness, and implementation. | Curr Probl Cardiol | 2026 | 42810479 | PubTator, text mining | PubMed |
| Baxdrostat (Baxfendy®), a first-in-class aldosterone synthase inhibitor approved for adults with uncontrolled hypertension. | Med Chem Res | 2026 | 42809094 | PubTator, text mining | PubMed |
| Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence-Response to Singh et al. | Clin Transplant | 2026 | 42804518 | PubTator, text mining | PubMed |
| Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension. | Life (Basel) | 2026 | 42795360 | PubTator, text mining | PubMed |
| Results from the Phase 2 Explore-CKD Trial of lorundrostat, a novel aldosterone synthase inhibitor, in participants with uncontrolled hypertension, chronic kidney disease, and albuminuria. | Kidney Int | 2026 | 42778148 | PubTator, text mining | PubMed |
| Identification of a novel small-molecule compound that suppresses depolarization-induced CYP11B2 expression and aldosterone production in KCNJ5 mutant adrenocortical cells. | Biochem Biophys Res Commun | 2026 | 42777615 | PubTator, text mining | PubMed |
| Clinical utilization of CYP17A1 and CYP11B2 in evaluating cortisol- and aldosterone-producing adrenal nodules. | Hum Pathol | 2026 | 42772699 | PubTator, text mining | PubMed |
| ADRB3, LEPR, FTO and PPARG variants contribute to obesity-related metabolic syndrome in Brazilian adults: a polygenic risk score approach. | Int J Obes (Lond) | 2026 | 42768086 | PubTator, text mining | PubMed |
| A Review Highlighting Emerging Frontiers in Hypertension Management: Integrating Novel Therapeutics and Holistic Approaches. | Curr Hypertens Rev | 2026 | 42736668 | PubTator, text mining | PubMed |
| Decoding Adrenal Cellular Heterogeneity in Primary Aldosteronism by Single-Cell Analysis. | Endocr Rev | 2026 | 42728670 | PubTator, text mining | PubMed |
| Efficacy and safety of lorundrostat in uncontrolled hypertension: a systematic review, meta-analysis, and meta-regression. | Ann Med Surg (Lond) | 2026 | 42724901 | PubTator, text mining | PubMed |
| Atrial Natriuretic Peptide Regulates Zona Glomerulosa Growth and Aldosterone Release. | Hypertension | 2026 | 42717871 | PubTator, text mining | PubMed |
| [Primary hyperaldosteronism : updates]. | Rev Med Suisse | 2026 | 42717610 | PubTator, text mining | PubMed |
| Pharmacokinetics of novel drugs for the treatment of diabetic nephropathy. | Expert Opin Drug Metab Toxicol | 2026 | 42709045 | PubTator, text mining | PubMed |
| Efficacy and Safety of Baxdrostat in Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Ann Pharmacother | 2026 | 42704049 | PubTator, text mining | PubMed |
| Mechanisms of Obesity-Related Kidney Disease: From Adipose Depot Biology to the Chymase-Aldosterone and Ghrelin-Leptin Axes. | Biomolecules | 2026 | 42650821 | PubTator, text mining | PubMed |
| Dkk3-Cyp11b2/aldosterone signaling couples ion-homeostatic failure to mitochondrial apoptosis in cochlear aging. | Cell Signal | 2026 | 42636949 | PubTator, text mining | PubMed |
| Baxdrostat: First Approval. | Drugs | 2026 | 42625106 | PubTator, text mining | PubMed |
| Dose-response efficacy and safety of the aldosterone synthase inhibitor baxdrostat in resistant hypertension: a systematic review and network meta-analysis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42624929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers